| human | Q5 |
| P106 | occupation | author | Q482980 |
| Q41857648 | (E)-13-(4-Amino-phen-yl)parthenolide |
| Q44805209 | A computational analysis on the specificity of interactions between histidine kinases and response regulators |
| Q44752266 | A single amino acid change in the binding pocket alters specificity of an anti-integrin antibody AP7.4 as revealed by its crystal structure |
| Q27670593 | ATP forms a stable complex with the essential histidine kinase WalK (YycG) domain |
| Q27681289 | Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering |
| Q43157346 | Amino acid identity at one position within the alpha1 helix of both the histidine kinase and the response regulator of the WalRK and PhoPR two-component systems plays a crucial role in the specificity of phosphotransfer |
| Q27667770 | Binding of -thrombin to surface-anchored platelet glycoprotein Ib sulfotyrosines through a two-site mechanism involving exosite I |
| Q34230990 | Conformational changes of Spo0F along the phosphotransfer pathway |
| Q53813042 | Corrigendum to "Sesquiterpene lactones from Gynoxys verrucosa and their anti-MRSA activity" [J. Ethnopharmacol. 137 (2011) 1055-1059]. |
| Q27658271 | Crystal structure of the transcriptional repressor PagR of Bacillus anthracis |
| Q27657455 | Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-Methamphetamine and 3,4-methylenedioxymethamphetamine |
| Q27639494 | DNA complexed structure of the key transcription factor initiating development in sporulating bacteria |
| Q82343620 | Interactions between the YycFG and PhoPR two-component systems in Bacillus subtilis: the PhoR kinase phosphorylates the non-cognate YycF response regulator upon phosphate limitation |
| Q37513913 | LIS1 Regulates Osteoclastogenesis through Modulation of M-SCF and RANKL Signaling Pathways and CDC42. |
| Q39344615 | LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation |
| Q47896448 | Metals in the sporulation phosphorelay: manganese binding by the response regulator Spo0F. |
| Q24307780 | Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha |
| Q33849095 | Molecular dynamics guided design of tocoflexol: a new radioprotectant tocotrienol with enhanced bioavailability |
| Q36559664 | Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease |
| Q48014711 | Platinum-induced space-group transformation in crystals of the platelet glycoprotein Ib alpha N-terminal domain |
| Q40702680 | Rebuttal: beryllofluoride binding mimics phosphorylation of aspartate in response regulators |
| Q34185108 | Red cell adenylate kinase deficiency: molecular study of 3 new mutations (118G>A, 190G>A, and GAC deletion) associated with hereditary nonspherocytic hemolytic anemia |
| Q35175840 | Sesquiterpene lactones from Gynoxys verrucosa and their anti-MRSA activity |
| Q53541021 | Sporulation phosphorelay proteins and their complexes: crystallographic characterization. |
| Q28536667 | Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites |
| Q52360911 | Structure and Inhibitor Specificity of L,D-Transpeptidase (LdtMt2) from Mycobacterium tuberculosis and Antibiotic Resistance: Calcium Binding Promotes Dimer Formation. |
| Q34790608 | Structure and function of the von Willebrand factor A1 domain |
| Q27641854 | Structure of pteridine reductase (PTR1) from Leishmania tarentolae |
| Q35844550 | Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein |
| Q36458284 | The crystal structure of YycH involved in the regulation of the essential YycFG two-component system in Bacillus subtilis reveals a novel tertiary structure |
| Q34697698 | The crystal structure of beryllofluoride Spo0F in complex with the phosphotransferase Spo0B represents a phosphotransfer pretransition state |
Search more.